Swedish team restores blood sugar control in diabetic mice

2026년 05월 07일

AI에 의해 보고됨

Researchers in Sweden have created insulin-producing cells from human stem cells that reversed diabetes symptoms when transplanted into mice. The cells matured after placement in the eye and maintained glucose regulation for months. The work was published in Stem Cell Reports.

Scientists at Karolinska Institutet developed an improved protocol to derive pancreatic islets from multiple human pluripotent stem cell lines. The method uses refined culture conditions and three-dimensional clusters to reduce unwanted cell types and enhance glucose responsiveness.

Health ministry panel conditionally approves iPS cell products

2026년 02월 20일 AI에 의해 보고됨 AI에 의해 생성된 이미지

A health ministry expert panel has conditionally approved two regenerative medicine products derived from induced pluripotent stem (iPS) cells for treating Parkinson's disease and severe heart disease. This marks a potential world first in commercializing Nobel Prize-winning stem cell technology. The approval, based on small-scale clinical trials confirming safety and presumed efficacy, requires post-market verification within seven years.

Researchers advance two-part therapy for type 1 diabetes

A team led by Leonardo Ferreira at the Medical University of South Carolina is developing a novel therapy combining lab-made insulin-producing cells with engineered immune cells to protect them. Funded by $1 million from Breakthrough T1D, the approach aims to restore beta cell function without immunosuppressive drugs. This strategy builds on prior research and targets all stages of the disease.

Scientists explain high altitude's protection against diabetes

2026년 02월 21일 AI에 의해 보고됨

Researchers have identified why living at high altitudes reduces diabetes risk: red blood cells absorb excess glucose in low-oxygen conditions. This metabolic shift lowers blood sugar levels, as shown in mouse experiments. A new drug mimicking this effect reversed diabetes in mice, suggesting potential treatments.

건강

Chinese team reports scalable way to generate large batches of engineered NK cells from cord-blood stem cells

건강

Swedish scientists develop scaffold for bone regeneration

건강

Study finds prediabetes remission possible without weight loss

Trojan horse obesity drug boosts weight loss in mice

Scientists have developed a hybrid obesity treatment that uses GLP-1 and GIP signals to deliver a metabolic enhancer directly into cells. Early tests in mice showed greater weight loss and better blood sugar control than standard therapies. The approach aims to reduce side effects by limiting the drug's action to targeted areas.

UC Riverside researchers report battery-powered oxygen gel that sped healing in diabetic mouse wounds

2026년 02월 22일 AI에 의해 보고됨 사실 확인됨

Researchers at the University of California, Riverside say they have developed a flexible, battery-powered gel patch that generates oxygen inside hard-to-heal wounds—an approach aimed at countering deep-tissue oxygen deprivation that can stall recovery and contribute to amputations. In experiments in diabetic and older mice, the team reported that wounds that often remained open—and were sometimes fatal—closed in about 23 days when treated with the oxygen-generating patch.

2026년 04월 16일 22시 03분